Franz Rischard
Experienced in Acute Interstitial Pneumonia

Dr. Franz Rischard

Pulmonary Medicine
Banner Health
Banner - University Medical Center Tucson Campus - Banner University Medicine North
3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
Accepting New Patients
Experienced in Acute Interstitial Pneumonia
Banner Health
Banner - University Medical Center Tucson Campus - Banner University Medicine North
3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

I enjoy advancing medicine through academics and excellent patient care.

Dr. Rischard is rated as an Experienced provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Cerebral Hypoxia, and Systemic Sclerosis (SSc).

His clinical research consists of co-authoring 83 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 2 clinical trials in the study of Acute Interstitial Pneumonia.

Graduate Institution
Western University Of Health Sciences, 2000
Residency
University of Arizona College of Medicine, Internal Medicine, 2003
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in AZ
Board Certifications
American Board Of Internal Medicine/Critical Care Medicine
American Board Of Internal Medicine/Pulmonary Disease
Fellowships
University of Arizona College of Medicine, Pulmonary Disease, 2006
Hospital Affiliations
Banner - University Medical Center South
Banner - University Medical Center Tucson
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Banner - University Medical Center Tucson Campus - Banner University Medicine North
3838 North Campbell Avenue, Building 2, Tucson, AZ 85719
Call: 520-694-8888
Other Locations
Banner-University Medical Center Tucson Campus
1625 North Campbell Avenue, Tucson, AZ 85719
Call: 520-694-0111
Banner - University Medical Group
2800 East Ajo Way, Tucson, AZ 85713
Call: 520-694-8888

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-004)
An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-004)
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients
Enrollment Status: Completed
Publish Date: May 13, 2025
Intervention Type: Other, Drug
Study Drug: Sotatercept
Study Phase: Phase 3
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated Interstitial Lung DiseasE and Pulmonary Hypertension (PH): The CRuSADE PH Study
Enrollment Status: Withdrawn
Publish Date: February 20, 2025
Intervention Type: Drug
Study Drug: Opsumit
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Completed
Publish Date: April 19, 2023
Intervention Type: Drug, Other
Study Drug: Sotatercept
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 10 Less Clinical Trials

83 Total Publications

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.
Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.
Journal: Circulation. Heart failure
Published: December 03, 2025
View All 83 Publications
Similar Doctors
Arista Chand
Advanced in Acute Interstitial Pneumonia
Dr. Arista Chand
Pulmonary Medicine
Advanced in Acute Interstitial Pneumonia
Dr. Arista Chand
Pulmonary Medicine

Banner - University Medicine North

3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
 (0.3 miles away)
520-694-8888
Languages Spoken:
English
See accepted insurances
Offers Telehealth

I like the outdoors and exploring Arizona. I especially like learning about different cultures and traditions, as well as ancient history and astronomy. Dr. Chand is rated as an Advanced provider by MediFind in the treatment of Acute Interstitial Pneumonia. Her top areas of expertise are Eosinophilic Pneumonia, Chronic Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Interstitial Lung Disease.

Advanced in Acute Interstitial Pneumonia
Dr. Ubair Ahmed
Pulmonary Medicine | Intensive Care Medicine
Advanced in Acute Interstitial Pneumonia
Dr. Ubair Ahmed
Pulmonary Medicine | Intensive Care Medicine

Tmc Medical Network

1951 N Wilmot Rd, Bldg 4, 
Tucson, AZ 
 (5.1 miles away)
520-318-1114
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Ubair Ahmed is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Tucson, Arizona. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Lung Metastases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Bronchiectasis. Dr. Ahmed is currently accepting new patients.

Experienced in Acute Interstitial Pneumonia
Dr. Khaled O. Hadeli
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Experienced in Acute Interstitial Pneumonia
Dr. Khaled O. Hadeli
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

Natrajan Enterprises PLLC

4318 E Desert Oak Trl, 
Tucson, AZ 
 (3.6 miles away)
520-447-7411
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Khaled Hadeli is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Tucson, Arizona. Dr. Hadeli is rated as an Advanced provider by MediFind in the treatment of Acute Interstitial Pneumonia. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Asthma, and Gastrostomy. Dr. Hadeli is currently accepting new patients.

VIEW MORE ACUTE INTERSTITIAL PNEUMONIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rischard's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Rischard is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Pulmonary Veno-Occlusive Disease
    Dr. Rischard is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Cerebral Hypoxia
    Dr. Rischard is
    Advanced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Rischard is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Bronchiectasis
    Dr. Rischard is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bullae
    Dr. Rischard is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Rischard is
    Experienced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Coccidioidomycosis
    Dr. Rischard is
    Experienced
    . Learn about Coccidioidomycosis.
    See more Coccidioidomycosis experts
  • Emphysema
    Dr. Rischard is
    Experienced
    . Learn about Emphysema.
    See more Emphysema experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.